Who Paid My Doc
Horng Lin
Diagnostic Radiology Salinas, CA Medical Doctor
NPI 1255395398 CMS profile 797439
559 Abbott St, Salinas, CA 93901
General payments
$94,481
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Horng Lin of Salinas, CA is reported in the CMS Open Payments database as having received $94,481 across 188 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $5,505 | 15 | |
| 2024 | General | $48,647 | 23 | |
| 2023 | General | $1,642 | 44 | |
| 2022 | General | $36,731 | 45 | |
| 2021 | General | $292 | 16 | |
| 2020 | General | $175 | 7 | |
| 2019 | General | $1,488 | 38 |
Beside peers
- Horng Lin
- Diagnostic Radiology median
- Middle half of Diagnostic Radiology
- National median
In program year 2025, general payments to Horng Lin were reported at $5,505. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.
Show as a table
| Year | Horng Lin | Diagnostic Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,488 | $108 | $29–$318 | $163 |
| 2020 | $175 | $65 | $21–$252 | $114 |
| 2021 | $292 | $92 | $24–$292 | $132 |
| 2022 | $36,731 | $104 | $29–$294 | $149 |
| 2023 | $1,642 | $110 | $29–$337 | $160 |
| 2024 | $48,647 | $113 | $30–$356 | $164 |
| 2025 | $5,505 | $112 | $32–$349 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
29
Drug cost
$21,772
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 29 | $21,772 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 318 billing codesPaid by Medicare
$1,443,334
Medicare patients
1,488
Services billed
11,557
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 52% | |
| Arthritis | 48% | |
| Chronic kidney disease | 45% | |
| Ischemic heart disease | 40% | |
| Heart failure | 36% | |
| Atrial fibrillation | 29% | |
| Depression | 26% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, alteplase recombinant, 1 mg J2997 | Office | 11 | 23 | $1,611 |
| Injection, fentanyl citrate, 0.1 mg J3010 | Office | 69 | 649 | $482 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 44 | 352 | $273 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 | Office | 49 | 2,324 | $245 |
| Injection, methylprednisolone acetate, 1 mg J1010 | Office | 21 | 1,920 | $195 |
| Injection, methylprednisolone acetate, 40 mg J1030 | Office | 13 | 29 | $146 |
| Injection, cefazolin sodium, 500 mg J0690 | Office | 52 | 77 | $49 |
| Injection, dexamethasone sodium phosphate, 1 mg J1100 | Office | 29 | 370 | $33 |
| Injection, midazolam hydrochloride, per 1 mg J2250 | Office | 71 | 242 | $26 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
188 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Diagnostic Radiology in California
Murray Reicher
Diagnostic Radiology · San Diego, CA
Agnes Santosa
Diagnostic Radiology · San Diego, CA
Robert Suh
Diagnostic Radiology · Los Angeles, CA
Jonathan Chung
Diagnostic Radiology · San Diego, CA
Gary Ulaner
Diagnostic Radiology · Los Angeles, CA
Garry Gold
Diagnostic Radiology · Stanford, CA
Related records
Diagnostic Radiology in California
Practitioners in the same specialty and state, ranked by reported value.
All Diagnostic Radiology
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.